Resverlogix Corp. (T.RVX) hit a new 52-week high of $3.49 Monday. Resverlogix announced that its Board of Directors has approved a proposal to spin out its subsidiary, RVX Therapeutics Inc. ,which will focus on innovative drug research and development by leveraging its epigenetics platform. RVX Therapeutics will exclude Apolipoprotein A-1 and RVX-208 technologies, rather focusing on multiple therapeutic indications including autoimmune diseases and cancer.
Equity Financial Holdings Inc. (T.EQI) hit a new 52-week high of $10.49 Monday. No news announcements today.
Lassonde Industries Inc. (T.LAS.A) hit a new 52-week high of $84.21 Monday. No news announcements today.
NuVista Energy Ltd. (T.NVA) hit a new 52-week high of $6.98 Monday. No news announcements today.
